Irgens HU, et al.. Long term mortality of mothers and fathers after pre-eclampsia: Population based cohort study. BMJ 2001; 323:1213–1217.
Ray JG, et al.. Cardiovascular health after maternal placental syndromes (CHAMPS): Population-based retrospective cohort study. Lancet 2005; 366:1797–1803.
Vikse BE, et al.. Previous preeclampsia and risk for progression of biopsy-verified kidney disease to end-stage renal disease. Nephrol Dial Transplant 2010; 25:3289–3296.
Mongraw-Chaffin ML, et al.. Preeclampsia and cardiovascular disease death: Prospective evidence from the child health and development studies cohort. Hypertension 2010; 56:166–171.
Kanasaki K, et al.. Deficiency in catechol-o-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature 2008; 453:1117–1121.
Bourghardt J, et al.. The endogenous estradiol metabolite 2-methoxyestradiol reduces atherosclerotic lesion formation in female apolipoprotein E-deficient mice. Endocrinology 2007; 148:4128–4132.
Roten LT, et al.. A low COMT activity haplotype is associated with recurrent preeclampsia in a Norwegian population cohort (HUNT2). Mol Hum Reprod 2011, in press.
Voutilainen S, et al.. Functional COMT Val158met polymorphism, risk of acute coronary events and serum homocysteine: The Kuopio ischaemic heart disease risk factor study. PLoS One 2007; 2:e181.
Morgan T, et al.. Angiotensinogen t235 expression is elevated in decidual spiral arteries. J Clin Invest 1997; 100:1406–1415.
Johansson A, et al.. Identification of ACOX2 as a shared genetic risk factor for preeclampsia and cardiovascular disease. Eur J Hum Genet 2011, in press.
Savvidou MD, et al.. Endothelial nitric oxide synthase gene polymorphism and maternal vascular adaptation to pregnancy. Hypertension 2001; 38:1289–1293.
Oney T, Kaulhausen H. The value of the angiotensin sensitivity test in the early diagnosis of hypertensive disorders in pregnancy. Am J Obstet Gynecol 1982; 142:17–20.
Wallukat G, et al.. Agonistic autoantibodies directed against the angiotensin II AT1 receptor in patients with preeclampsia. Can J Physiol Pharmacol 2003; 81:79–83.
Herse F, et al.. Dysregulation of the circulating and tissue-based renin-angiotensin system in preeclampsia. Hypertension 2007; 49:604–611.
Saxena AR, et al.. Increased sensitivity to angiotensin II is present postpartum in women with a history of hypertensive pregnancy. Hypertension 2010; 55:1239–1245.
Brodszki J, et al.. Vascular mechanical properties and endothelial function in pre-eclampsia with special reference to bilateral uterine artery notch. Acta Obstet Gynecol Scand 2008; 87:154–162.
Yinon Y, et al.. Vascular dysfunction in women with a history of preeclampsia and intrauterine growth restriction: Insights into future vascular risk. Circulation 2010; 122:1846–1853.
Sugawara J, et al.. Decrease and senescence of endothelial progenitor cells in patients with preeclampsia. J Clin Endocrinol Metab 2005; 90:5329–5332.
Luppi P, et al.. Maternal circulating cd34+vegfr-2+ and cd133+vegfr-2 + progenitor cells increase during normal pregnancy but are reduced in women with preeclampsia. Reprod Sci 2010; 17:643–652.
Romundstad PR, et al.. Hypertension in pregnancy and later cardiovascular risk: Common antecedents? Circulation 2010; 122:579–584.